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ABSTRACT: Transition-metal catalysis is a powerful tool for the 
construction of chemical bonds. Here we show that a non-heme 
iron enzyme can catalyze olefin aziridination and nitrene C–H in-
sertion, and that these activities can be improved by directed evo-
lution. The non-heme iron center allows for facile modification of 
the primary coordination sphere by addition of metal-coordinating 
molecules, enabling control over enzyme activity and selectivity 
using small molecules. 
Over the last century, chemists have developed myriad synthetic 
transition-metal catalysts to access new chemical transformations 
and modes of reactivity. Nature has been developing catalysts for 
far longer: over billions of years, she has evolved a rich repertoire 
of proteins that perform most of the chemical reactions of life. But 
nature’s inventions do not include many of the best inventions of 
human chemists. Our efforts to merge abiological transition-metal 
chemistry with nature’s vast toolbox of metalloproteins have fo-
cused on heme-binding proteins1, as the heme cofactor and its ana-
logues are well-studied in synthetic transition-metal chemistry. 
However, heme-binding proteins represent only a small fraction of 
the chemical diversity present in natural metalloproteins. Metallo-
proteins comprise greater than 30% of all proteins2 and are respon-
sible for some of the most fundamental chemical reactions in biol-
ogy, including nitrogen fixation, photosynthesis, and DNA synthe-
sis. Natural metalloproteins bind a variety of metals in a wide range 
of metal-binding sites, either coordinating the metal ion itself or a 
more complex metal-containing cofactor. Nearly any heteroatom-
containing side chain can coordinate to a metal, in addition to the 
peptide backbone, allowing myriad possible coordination environ-
ments3. Many coordination environments in non-heme metalloen-
zymes have multiple open coordination sites at the metal center, a 
key feature of numerous synthetic transition-metal catalysts. Ex-
panding new-to-nature catalysis to non-heme metalloenzymes 
would open a new world of transition-metal biocatalysis.  
For decades, humans have used small-molecule ligands to un-
derstand and control Nature’s catalysts. Nature employs allostery 
to regulate enzyme activity with small molecules (Figure 1A). Al-
losteric regulation of enzymes has been studied at length4 and there 
have been successful examples of engineered5 or designed6 allo-
steric enzyme regulation, but allostery is still challenging to under-
stand or adapt to engineered systems. Cofactor-dependent en-
zymes, in which a small molecule is directly involved in catalysis, 
are often more readily understood and more easily manipulated by 
small molecules. Biochemists have knocked out catalytic activity 
via mutagenesis and restored it with exogenous effectors7 and sub-
stituted native cofactors with synthetic analogues with altered prop-
erties8. In the case of heme-binding proteins, scientists have substi-
tuted the metal ion9 or modified the porphyrin prosthetic group10 to 
modulate or expand enzymatic activity. A non-heme metallopro-
tein, in which a metal ion is coordinated directly by the protein and 
by exogenous small molecules, would allow for direct manipula-
tion of the primary metal coordination environment. 
 
Figure 1. Examples of enzyme activity control using small mole-
cules. (A) ADP acts as a natural allosteric regulator of phosphofruc-
tokinase (PDB ID: 4PFK). (B) Non-natural analogues of ATP act 
as competitive inhibitors of ATP-dependent enzymes (PDB ID: 
1I5A).  (C) This work: small-molecule activation of a non-heme 
iron center for nitrene transfer.   
 To search for abiological catalytic promiscuity among natural 
metalloproteins, we looked at α-ketoglutarate (αKG)-dependent 
iron enzymes, a family of enzymes which features a conserved 
metal-binding active site with iron coordinated by two histidines 
and one aspartate or glutamate11. In nature, these enzymes perform 
similar chemistry to the heme-binding cytochrome P450 family, in 
which a high-valent iron-oxo intermediate performs C–H hydrox-
ylation, olefin epoxidation, or other oxidative transformations12. 
Though members of this enzyme family have been reported to cat-
alyze reactions beyond their native functions, all the reactions re-
ported proceed through the native iron-oxo mechanism13. We hy-
pothesized that non-heme iron enzymes might also be able to cata-
lyze abiological transformations similar to heme-binding proteins 
through a non-natural mechanistic pathway. 
We screened a set of seven purified α-ketoglutarate (αKG)-de-
pendent iron dioxygenases against the intermolecular aziridination 
reaction of styrene 1 and p-toluenesulfonyl azide 2. Aziridination14 
and carbon–hydrogen (C–H) bond insertions of nitrenes15 have 
been reported using engineered heme-binding proteins and were 
subsequently proposed in a natural product biosynthetic pathway16. 
Chang et al. speculated the existence of a transient iron-nitrene in-
termediate in their report of the transformation of alkyl azides to 
nitriles by an αKG-dependent iron dioxygenase, but this reaction 
still proceeds through the canonical iron-oxo catalytic cycle13b. To 
date, no reported non-heme iron enzyme, natural or engineered, has 
been reported to catalyze productive nitrene transfer.  
From the set of enzymes we tested, only Pseudomonas savas-
tanoi ethylene-forming enzyme (PsEFE, UniProt ID P32021), 
formed aziridine 3 significantly above background (Supplementary 
Table S2). Compared to other members of the αKG-dependent iron 
dioxygenase family PsEFE is mechanistically and structurally dis-
tinct. While most enzymes of this family catalyze the oxidation of 
a substrate, often C–H hydroxylation, PsEFE natively catalyzes the 
fragmentation of the usual co-substrate α‑ketoglutarate to ethylene, 
as well as the hydroxylation of L-arginine17. Structurally, PsEFE 
possesses a hybrid fold, combining elements of both type I and 
type II αKG-dependent iron enzymes. It binds α-ketoglutarate in a 
strained conformation in an unusually hydrophobic pocket, which 
is likely responsible for the atypical catalytic activity18. 
As the iron-binding site in PsEFE is quite unlike that of the 
heme-binding proteins that perform nitrene-transfer chemistry, we 
sought to characterize the necessary components of the reaction. 
Iron is required, with a single added equivalent of iron(II) sufficient 
to fully restore catalytic activity of the wild-type apoenzyme.  
PsEFE has three coordination sites filled by amino-acid side chains 
(two histidines and one aspartate), leaving up to three additional 
sites open for binding. In the native catalytic mechanism of PsEFE 
and other members of its family, α-ketoglutarate occupies two of 
these sites and is required for activity, as it is oxidatively decarbox-
ylated to succinate to generate the reactive iron-oxo intermediate. 
PsEFE has been shown to catalyze arginine hydroxylation with α-
ketoadipate instead of α-ketoglutarate, but with 500-fold lower ac-
tivity. Other α-ketoacids were reported to give no activity19. 
Nitrene transfer, however, does not proceed through the native cat-
alytic cycle and therefore does not require αKG as a co-substrate; 
the αKG is now more a cofactor and as such could potentially be 
replaced by different small-molecule ligands. Intrigued by the pos-
sibility of modulating enzyme activity by changing the primary co-
ordination sphere of the catalytic iron, we tested PsEFE for aziridi-
nation with a set of α-ketoglutarate mimics and related molecules 
as additives. We found that whereas addition of a carboxylate is 
beneficial for activity (though not required), the wild-type enzyme 
is significantly more active for aziridination with added acetate or 
N-oxalylglycine (NOG, a general αKG-dependent enzyme compet-
itive inhibitor11) compared to α-ketoglutarate (Table 1). 
Table 1. Aziridination catalyzed by wild-type PsEFE 
 
Deviation from standard conditions1 Relative activity 
None 1.00 
No iron 0.08 
No αKG 0.52 
Acetate2 instead of αKG 6.72 
N-oxalylglycine3 instead of αKG 7.75 
Acetate instead of αKG, no ascorbic acid 6.01 
1Standard conditions: Reactions were performed in MOPS 
buffer (20 mM pH 7.0) with 5% ethanol co-solvent, with 20 μM 
apoenzyme, 1 mM Fe(NH4)2(SO4)2, 1 mM αKG (as disodium 
salt), 1 mM L-ascorbic acid, and 10 mM 1 and 2. 2Sodium salt. 
3Free acid. 
We then sought to improve PsEFE for aziridination via directed 
evolution, targeting active-site residues with site-saturation muta-
genesis and screening for enhanced activity. During directed evo-
lution, we screened with added acetate, as it enhanced the activity 
of the wild-type enzyme significantly more than the native α-ke-
toglutarate, it is biologically ubiquitous, and it is inexpensive. Alt-
hough α-ketoglutarate is the native cofactor and is naturally present 
at near-millimolar intracellular concentration in Escherichia coli20, 
we reasoned that by supplementing the reaction medium with ace-
tate we could evolve PsEFE to be dependent on acetate instead.  
After two rounds of site-saturation mutagenesis and one round 
of recombination, we found a variant with five mutations from the 
wild type (T97M R171L R277H F314M C317M, PsEFE 
MLHMM) which catalyzed the formation of 3 with 120 total turn-
over number (TTN) and 88% enantiomeric excess (ee) favoring the 
(R)-enantiomer (Figure 2A). Four of the five introduced mutations 
are in the binding pocket of the native substrate arginine and pre-
sumably are involved in substrate binding. The fifth beneficial mu-
tation is at Arg-277, the residue whose guanidino group natively 
binds the distal carboxylate of α-ketoglutarate (Figure 2B). The 
R277H mutation presumably abolishes binding of the native cofac-
tor α-ketoglutarate; as a result, PsEFE MLHMM shows no signifi-
cant increase in aziridination activity when α-ketoglutarate is 
added, but an 11-fold increase when acetate is added (Supplemen-
tary Table S4). Thus the evolved MLHMM variant is more acti-
vated by acetate than the wild type and is no longer activated by α-
ketoglutarate at all, demonstrating the tunability of the cofactor de-
pendence of PsEFE. 
      
Figure 2. Directed evolution of PsEFE for aziridination. (A) Evolutionary lineage. Reactions were performed in triplicate anaerobically with 
acetate and quantified by analytical HPLC-UV. Full experimental details are given in the Supporting Information. (B) Structural representa-
tion of PsEFE with mutated sites highlighted in orange; metal-coordinating residues H189, D191, and H268 are represented in sticks and 
Mn (the metal with which the protein was crystallized) is represented as a purple sphere (PDB ID: 6CBA). 
We reasoned that variants of PsEFE generated by directed evo-
lution for aziridination could exhibit promiscuous activity for addi-
tional nitrene-transfer reactions beyond aziridination. Screening a 
panel of variants for the intramolecular C–H bond insertion reac-
tion of 2-ethylbenzenesulfonyl azide 4 to form sultam 5, we identi-
fied multiple variants that perform this reaction with good TTN, 
excellent chemoselectivity, and moderate enantioselectivity. Re-
markably, PsEFE R171V F314M C317M (PsEFE VMM) is signif-
icantly more active and more chemo- and enantioselective with N-
oxalylglycine added than with either acetate or α-ketoglutarate, 
forming 5 with up to 730 TTN and greater than 100:1 selectivity 
for insertion over reduction (Table 2). This chemoselectivity is 
much higher than that of the heme proteins previously reported to 
catalyze similar reactions15a,b. To probe the specific effect of cofac-
tor binding on activity, we tested PsEFE R171V R227H F314M 
C317M (PsEFE VHMM), a variant in which αKG and NOG bind-
ing are disrupted by the R277H mutation. Whereas PsEFE 
VHMM’s activity is still enhanced nearly ten-fold with acetate, 
there is no significant difference between its activity with no addi-
tive, αKG, or NOG added to the reaction (Table 2). αKG or its an-
alogues therefore appear to bind within the native αKG binding 
site, activating the protein through the primary metal coordination 
sphere. 
Aziridination with PsEFE is reasonably oxygen tolerant, with the 
MLHMM variant maintaining 20% activity for aziridination when 
performed in air. C–H insertion, however, does not proceed detect-
ably in aerobic conditions with any variant tested. These observa-
tions suggest that formation of the putative iron-nitrene intermedi-
ate is not significantly inhibited by oxygen, but that a subsequent 
mechanistic step in the C–H insertion reaction is inhibited aerobi-
cally. Unlike nitrene transfer with heme proteins15a, an additional 
reductant is not required when reactions are performed anaerobi-
cally (Supplementary Table S4).  
 
Table 2. Nitrene C–H insertion catalyzed by PsEFE 
 
PsEFE variant Additive TTN (5) ee (%) 5/6 
Wild type Acetate 12 n.d.1 1.6 
VHMM None 27 n.d.1 3.4 
VHMM αKG 31 n.d.1 3.8 
VHMM Acetate 240 7.3 32 
VHMM NOG 33 n.d.1 4.1 
VMM None 25 n.d.1 0.9 
VMM αKG 130 61 9.0 
VMM Acetate 310 9.4 24 
VMM NOG 450 48 105 
VMM2 NOG 730 47 100 
Reactions were performed anaerobically in MOPS buffer 
(20 mM pH 7.0) with 2.5% ethanol co-solvent, 20 μM apoenzyme, 
1 mM Fe(NH4)2(SO4)2, 1 mM additive, 1 mM L-ascorbic acid, and 
10 mM 4 (maximum 500 TTN). Reactions were quantified by ana-
lytical HPLC-UV. TTNs are shown for 5 only. 1Not determined due 
to low conversion. 210 μM enzyme concentration (max. 1000 
TTN). 
PsEFE is highly expressed (>200 mg/L E. coli culture) and is 
catalytically active in whole E. coli cells and in cell lysate. We ob-
serve that in cell lysate the enzyme maintains high activity with no 
external additive; the enzyme presumably retains a cofactor from 
the intracellular environment during lysis. Addition of N-oxalylgly-
cine nevertheless enhances C–H insertion yield and chemoselectiv-
ity when PsEFE VMM is in cell lysate. In whole cells, however, 
A B 
 there is no significant change upon addition of N-oxalylglycine 
(Supplementary Table S6). This is unsurprising as N-oxalylglycine 
is not reported to be cell-permeable. Future biochemical studies and 
further mutagenesis will likely enhance the selectivity for cofactor 
analogues and impart in vivo activation to PsEFE variants. 
In conclusion, we have discovered a non-heme iron enzyme ca-
pable of performing nitrene-transfer chemistry and enhanced that 
activity via directed evolution. This is the first example of enzy-
matic nitrene transfer catalyzed by a non-heme metalloprotein. 
PsEFE features a metal center whose primary coordination sphere 
can be altered by simple reaction additives, allowing for modula-
tion of catalytic activity and selectivity. We anticipate that this bi-
ocatalytic system will lead to discovery of new metalloenzymatic 
transformations not possible with previously reported enzymes. 
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MATERIALS AND METHODS 
Synthetic chemistry 
All manipulations were performed using oven-dried glassware (130 °C for a minimum of 12 hours) and standard 
Schlenk techniques under an atmosphere of argon, unless otherwise stated.  
Solvents 
ACS- and HPLC-grade solvents were purchased from Fisher Chemical. Anhydrous tetrahydrofuran was 
obtained by filtration through a drying column and a deoyxgenation column on a Pure Process Technologies 
solvent system. High-purity water for PCR and HPLC was distilled after filtration through a deionizing column 
and organic removal column. Deuterated solvents were purchased from Cambridge Isotope Laboratories. 
Chromatographic materials  
Thin layer chromatography (TLC) was performed using EMD TLC plates pre-coated with 250 μm thickness 
silica gel 60 F254 and visualized by fluorescence quenching under UV light and staining with potassium 
permanganate or cerium ammonium molybdate. Preparative flash chromatography was performed using a 
Biotage Isolera automated chromatography instrument using columns hand-packed with silica gel (230–
400 mesh, Silicyle Inc.). 
Starting materials 
All compounds were used as received from commercial suppliers, unless otherwise stated.  
Analytical instrumentation 
HPLC-MS analysis for initial activity determination was performed on an Agilent 1290 UPLC-MS equipped with 
a C18 silica column (1.8 μm packing, 2.1×50 mm). HPLC-MS analysis of site-saturation mutagenesis libraries 
was performed on an Agilent 1260 Infinity HPLC with an Agilent 6120 quadrupole mass spectrometer. Reverse-
phase HPLC-UV analysis was performed with an Agilent 1200 series HPLC or an Agilent 1260 Series Infinity 
II HPLC using an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a Poroshell 120 
guard column (1.7 μm packing, 2.1×5 mm). Normal-phase HPLC-UV analysis for chiral separations was 
performed with a Hewlett Packard Series 1100 HPLC instrument using a Daicel Chiralcel OJ-H column, (5 μm 
packing, 4.6×250 mm) or a Daicel Chiralpak IB column (5 μm packing, 4.6×250 mm). 
NMR spectra were recorded on a Varian Unity/Inova 500 spectrometer operating at 500 MHz and 125 MHz for 
1H and 13C respectively, or a Bruker Avance 400 spectrometer operating at 400 MHz and 100 MHz for 1H and 
13C respectively. NMR data were analyzed in MestReNova (MestreLab Research). Chemical shifts are reported 
in ppm with the solvent resonance as the internal standard. For 1H NMR: CDCl3,  7.26. For 13C NMR: CDCl3, 
 77.16. Data are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, spt = septet, m = multiplet, 
br = broad; coupling constants in Hz; integration. 
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Biology and biocatalytic reactions 
Materials 
Oligonucleotides were purchased from IDT DNA. PCRs were run with Phusion® High-Fidelity PCR Kit (New 
England Biolabs). Gibson assembly mix1 is prepared with isothermal master mix in-house and enzymes T5 
exonuclease, Phusion® DNA polymerase, and Taq DNA ligase purchased from New England Biolabs.   
Cloning 
Plasmids encoding Pseudomonas savastanoi ethylene-forming enzyme (Uniprot ID P32021), Streptomyces sp. 
2-aminobutyric acid chlorinase (UniProt ID D0VX22), and Arabidopsis thaliana anthocyanidin synthase 
(UniProt ID Q96323), with the coding sequences codon-optimized for Escherichia coli were purchased from 
Twist Biosciences. Plasmids encoding Gluconobacter oxydans leucine dioxygenase (UniProt ID Q5FQD2), 
Streptomyces vinaceus arginine hydroxylase (UniProt ID Q6WZB0), and Streptomyces muensis leucine 
hydroxylase (UniProt ID A0A0E3URV8) were obtained from the laboratory of Prof. Hans Renata (Scripps 
Research Institute). The plasmid encoding Escherichia coli taurine dioxygenase (UniProt ID P37610) was 
obtained from the laboratory of Prof. Harry Gray (Caltech). All genes were encoded with a C-terminal His6-tag 
for purification and inserted between the NdeI and XhoI cut sites in the pET-22b(+) vector (Novagen).  
Plasmids were used to transform E. cloni BL21(DE3) cells (Lucigen) by electroporation. SOC medium (0.75 mL) 
was added and the cells were incubated at 37 °C for 45 minutes before being plated on Luria-Bertani medium 
(Research Products International) supplemented with ampicillin (100 μg mL-1, LB-amp) agar plates. 
Protein expression and purification 
Starter cultures of LB-amp were inoculated from a single E. coli colony on an agar plate harboring a plasmid 
encoding the protein of interest and grown overnight to stationary phase at 37 °C. Expression cultures of Terrific 
Broth (Research Products International) supplemented with ampicillin (100 mg L-1, TB-amp) were inoculated 
from the starter cultures (1% v/v) and shaken at 37 °C and 160 rpm in a Multitron Infors incubator. When the 
expression cultures reached OD600 ~ 0.8 (typically 2–3 hours), they were cooled on ice for 20 minutes. Protein 
expression was induced by addition of isopropyl β-D-1-thiogalactopyranoside (IPTG, 0.5 mM). Cultures were 
incubated at 22 °C and 110 rpm overnight (16–24 hours). Cells were pelleted by centrifugation (5000×g, 
10 minutes).  
For reactions with whole cells, cell pellets were resuspended in MOPS buffer (20 mM pH 7.0) to OD600 30. For 
reactions with cell lysate, the whole cell suspensions were lysed by sonication (QSonica Q500 sonicator, 25% 
amplitude, 33% duty cycle, 3 minutes). The lysate was clarified by centrifugation (20,817×g, 10 minutes). 
For purification, cell pellets were frozen at −20 °C for at least 24 hours. Cells were resuspended in binding 
buffer (20 mM Tris∙HCl, 100 mM sodium chloride, 20 mM imidazole, pH 7.0, ~5 mL/g wet cells) and lysed by 
 
1 Gibson, D.G.; Young, L.; Chuang, R.-Y.; Venter, J.C.; Hutchison, C.A. III; Smith, H.O. Enzymatic assembly of DNA molecules up to 
several hundred kilobases. Nat. Methods 2009, 6, 343–345. 
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sonication (QSonica Q500 sonicator, 25% amplitude, 33% duty cycle, 4 minutes). The lysate was clarified by 
centrifugation (20,817 g, 10 minutes) followed by filtration (0.45 μm syringe filter). The protein was purified 
using an Äkta Purifier with a HisTrap HP column (GE Healthcare), eluting with a gradient of 20–500 mM 
imidazole. Fractions containing the protein of interest were pooled and dialyzed at 4 °C against MOPS buffer 
(20 mM pH 7.0) containing 1 mM EDTA (>100:1 v/v) (Spectrum Laboratories Spectra/Por 12–14 kD membrane) 
for four hours, then against MOPS buffer (20 mM pH 7.0) overnight (12–16 hours). The dialyzed protein was 
concentrated by centrifugal filtration (Amicon Ultra-15 10 kD MWCO) to a final concentration of 40–
100 mg mL−1. The concentrated protein was divided into aliquots (50–100 μL), flash-frozen on powdered dry 
ice, and stored at −80 °C. Protein concentration was determined by Bradford assay (Bio-Rad Quick Start 
Bradford). 
Site-saturation mutagenesis and library screening 
Site-saturation mutagenesis was performed using the 22-codon method2. Oligonucleotides including the three 
22-codon trick codons (NDT, VHG, TGG) and oligos within the ampicillin resistance cassette were used to 
amplify the plasmid in two pieces; oligo sequences are listed in Table S1. The two pieces were assembled via 
isothermal Gibson assembly (50 °C, 1 hour). The Gibson assembly product was used directly to transform E. 
cloni BL21(DE3) cells (Lucigen) by electroporation. SOC medium (0.75 mL) was added and the cells were 
incubated at 37 °C for 45 minutes before being plated on LB-amp agar plates. Single colonies from the agar 
plates were picked with sterile toothpicks and used to inoculate starter cultures (0.5 mL LB-amp) in 96 deep-
well plates. The starter culture plates were grown at 37 °C, 250 rpm, and 80% humidity in a Multitron Infors 
shaker overnight (14–16 hours). The starter cultures (50 μL) were used to inoculate expression cultures (1 mL 
TB-amp) in 96 deep-well plates. In parallel, glycerol stock plates were prepared for long-term storage by mixing 
starter culture (50 μL) with sterile glycerol (50% v/v, 50 μL) and frozen at −80 °C. The expression cultures were 
grown at 37 °C, 250 rpm, and 80% humidity for three hours, then cooled on ice for 20 minutes. Protein 
expression was induced by addition of IPTG (0.5 mM). Cultures were incubated at 22 °C and 220 rpm overnight 
(18–20 hours). Cells were pelleted (5000×g, 5 minutes) and the cell pellets were frozen at −20 °C for at least 
24 hours prior to use. 
Cells were resuspended in MOPS buffer (20 mM pH 7.0) containing 1 mM sodium acetate. Under air, ferrous 
ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration, prepared immediately before use), L-
ascorbic acid (40 mM in water, 10 μL, 1 mM final concentration, prepared immediately before use), styrene 
(400 mM in ethanol, 10 μL, 10 mM final concentration), and p-toluenesulfonyl azide (400 mM in ethanol, 10 μL, 
10 mM final concentration) were added to each well. The plates were sealed with foil covers and shaken at 
room temperature for two hours. To quench the reactions, acetonitrile (400 μL) was added and the reaction 
plate was shaken for an additional 30 minutes. Insoluble material was pelleted by centrifugation (6000×g, 
10 minutes) and 200 μL of the supernate was filtered through a 0.2 μm PTFE 96-well filter plate into a 96-well 
 
2 Kille, S.; Acevedo-Rocha, C.G.; Parra, L.P.; Zhang, Z.-G..; Opperman, D.J.; Reetz, M.T.; Acevedo, J.P. Reducing Codon Redundancy 
and Screening Effort of Combinatorial Protein Libraries Created by Saturation Mutagenesis. ACS Synth. Biol. 2013, 2, 83–92. 
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microplate (3000×g, 2 minutes). The microplate was sealed with a pierceable cover and analyzed via HPLC-
MS (Analytical instrumentation). 
Table S1. Oligonucleotides used for mutagenesis. Mutated codons are denoted here as NNN for simplicity; in 
practice they are a 12:9:1 ratio of NDT:VHG:TGG for site saturation or the appropriate single codon for site-
directed mutagenesis. 
Mutations 
relative to 
wild type Direction Sequence 
T97X Forward CCGACTTCCCCGAAATTTTCNNNGTCTGCAAAGATCTTTC 
T97X Reverse GAAAATTTCGGGGAAGTCGGGCTTTCCAGCAGTCACCTC 
R171X Forward GATGGATGGCACCACATGNNNGTGTTGCGTTTTCCGCC 
R171X Reverse CATGTGGTGCCATCCATCGCGGGTCAAATCTG 
R277X Forward GGTGAAACTTAATACACGTGAGNNNTTTGCTTGCGCGTACTTCCATGAGCCG 
R277X Reverse CACGTGTATTAAGTTTCACCTTATGCGGAGTGCTAAGTAACTGTCCCCCG 
F314X 
C317M 
Forward CACTATGGGGAACATTTCACGAACATGNNNATGCGTATGTATCCTGACCG 
F314X Reverse CATGTTCGTGAAATGTTCCCCATAGTGAATGCGCTCATTGGCC 
C317X Forward TCACGAACATGTTCATGCGTNNNTATCCTGACCGCATTACCACACAGC 
C317X Reverse CATGAACATGTTCGTGAAATGTTCCCCATAGTGAATGCGCTC 
Analytical-scale biocatalytic aziridination reactions 
Biocatalytic reactions were set up in 2-mL screw-cap vials (Agilent). Purified apoprotein (350 μL, 22.9 μM in 
20 mM MOPS pH 7.0, final concentration 20 μM) was added to the vial. Solutions of ferrous ammonium sulfate 
and L-ascorbic acid were prepared immediately prior to use. Reactions to be set up anaerobically were brought 
into a Coy vinyl anaerobic chamber (nitrogen atmosphere, 0–10 ppm oxygen). To each reaction was added in 
order ferrous ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration), sodium acetate or other 
additive (40 mM in water, 10 μL, 1 mM final concentration), and L-ascorbic acid (40 mM in water, 10 μL, 1 mM 
final concentration). Each reaction was then charged with styrene (400 mM in ethanol, 10 μL, 10 mM final 
concentration) immediately followed by p-toluenesulfonyl azide (400 mM in ethanol, 10 μL, 10 mM final 
concentration, 500 max. TTN). The reactions were sealed and shaken at room temperature for three hours 
unless otherwise noted. To quench the reactions, acetonitrile (350 μL) was added to each vial, followed by 
internal standard propiophenone (0.1% v/v in acetonitrile, 50 μL). The sample was transferred to a 1.7-mL 
Eppendorf tube, vortexed, and then centrifuged (20817×g, 5 minutes). 250 μL of the supernate was transferred 
to HPLC vial inserts for reverse-phase HPLC analysis. The remaining supernate was partially concentrated in 
vacuo to remove acetonitrile and ethanol. Cyclohexane (500 μL) was added to the resulting aqueous 
suspension. The mixture was thoroughly shaken and then centrifuged (20817×g, 5 minutes). 250 μL of the 
organic layer was transferred to HPLC vial inserts for normal-phase chiral HPLC analysis. 
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Analytical-scale biocatalytic C–H insertion reactions 
Biocatalytic reactions were set up in 2-mL screw-cap vials (Agilent). Purified apoprotein (360 μL, 22.2 μM in 
20 mM MOPS pH 7.0, final concentration 20 μM) was added to the vial. Solutions of ferrous ammonium sulfate 
and L-ascorbic acid were prepared immediately prior to use. Reactions to be set up anaerobically were brought 
into a Coy vinyl anaerobic chamber (nitrogen atmosphere, 0–10 ppm oxygen). To each reaction was added in 
order ferrous ammonium sulfate (40 mM in water, 10 μL, 1 mM final concentration), sodium acetate or other 
additive (40 mM in water, 10 μL, 1 mM final concentration), L-ascorbic acid (40 mM in water, 10 μL, 1 mM final 
concentration). Each reaction was then charged with 2-ethylbenzenesulfonyl azide (400 mM in ethanol, 10 μL, 
10 mM final concentration, 500 max. TTN). The reactions were sealed and shaken at room temperature for six 
hours unless otherwise noted. To quench the reactions, acetonitrile (350 μL) was added to each vial, followed 
by internal standard propiophenone (0.5% v/v in acetonitrile, 50 μL). The sample was transferred to a 1.7-mL 
Eppendorf tube, vortexed, and then centrifuged (20817×g, 5 minutes). 250 μL of the supernate was transferred 
to HPLC vial inserts for reverse-phase HPLC analysis. The remaining supernate was partially concentrated in 
vacuo to remove acetonitrile and ethanol. Hexanes (250 μL, HPLC grade) and ethyl acetate (250 μL, HPLC 
grade) were added. The resulting mixture was thoroughly shaken and then centrifuged (20817×g, 5 minutes). 
250 μL of the organic layer was transferred to HPLC vial inserts for normal-phase chiral HPLC analysis. 
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EXPERIMENTAL DATA 
Initial evaluation of α-ketoglutarate-dependent iron dioxygenases 
 
Reactions were performed as described above (Analytical-scale biocatalytic aziridination reactions) except 
enzyme concentrations were 50 μM, disodium α-ketoglutarate was used as the additive, and acetonitrile was 
used as the co-solvent. Activity was assayed by HPLC-MS (Analytical instrumentation). Activities are 
normalized to the negative control, bovine serum albumin. 
Table S2. Activities of α-KG-dependent iron enzyme towards aziridination to form 3. 
Enzyme Relative activity 
P. savastanoi ethylene-forming enzyme 12.0 
Streptomyces sp. 2-aminobutyric acid chlorinase 0.93 
A. thaliana anthocyanidin synthase 0.54 
G. oxydans leucine dioxygenase 1.11 
E. coli taurine dioxygenase 0.61 
S. vinaceus arginine hydroxylase 0.57 
S. muensis leucine hydroxylase 0.61 
Bovine serum albumin (negative control) 1.00 
 
Reaction condition controls 
Aziridination reaction 
 
Reactions were performed in triplicate as described above with acetate as additive (Analytical-scale biocatalytic 
aziridination reactions) except where noted. Yields given are the average of the triplicates. 
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Table S3. Aziridination reaction controls with wild-type PsEFE. 
Deviation from standard conditions Aziridine yield (%) 
None 0.56% 
No iron 0.01% 
No ascorbate 0.50% 
No acetate 0.04% 
αKG instead of acetate 0.08% 
Succinate instead of acetate 0.11% 
N-oxalylglycine instead of acetate 0.64% 
 
Table S4. Aziridination reaction controls with PsEFE T97M R171L R277H F314M C317M 
Deviation from standard conditions Aziridine yield (%) 
None 23.8 
No iron 0.1 
No ascorbate 15.2 
No acetate 2.1 
α-Ketoglutarate instead of acetate 2.6 
N-oxalylglycine instead of acetate 2.4 
Aerobic 4.7 
Aerobic, no ascorbate 2.9 
 
C–H insertion reaction 
 
Reactions were performed in triplicate as described above (Analytical-scale biocatalytic C–H insertion 
reactions) with acetate as the additive, except where otherwise noted. Data shown are the average of the 
triplicates. 
Table S5. C–H insertion reaction controls (max. 500 TTN) 
Variant Additive TTN (5) 5/6 
Wild type Acetate 12.3 1.6 
R171V F314M C317M Acetate 313 24 
R171V F314M C317M None 24.6 0.9 
R171V F314M C317M α-Ketoglutarate 130 9.0 
R171V F314M C317M N-Oxalylglycine 447 105 
R171V R277H F314M C317M Acetate 243 32 
R171V R277H F314M C317M None 27.0 3.4 
R171V R277H F314M C317M α-Ketoglutarate 30.8 3.8 
R171V R277H F314M C317M N-Oxalylglycine 33.3 4.1 
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C–H insertion reaction with whole cells and cell lysate 
Reactions were performed in triplicate as described above (Analytical-scale biocatalytic C–H insertion 
reactions), except whole cell suspensions and cell lysates were used instead of purified protein solutions. Data 
shown are the average of the triplicates. Note that the chemoselectivities are generally much lower than with 
purified protein; this is presumably due to increased reduction by the cellular background. 
Table S6. C–H insertion with whole cells and lysate 
Variant Formulation Additive % Yield (5) 5/6 
VMM Whole cells None 36% 1.6 
VMM Whole cells Acetate 37% 1.7 
VMM Whole cells αKG 36% 1.6 
VMM Whole cells NOG 30% 1.6 
VMM Lysate None 76% 7.7 
VMM Lysate Acetate 72% 7.0 
VMM Lysate αKG 69% 6.3 
VMM Lysate NOG 90% 12.7 
VHMM Whole cells None 33% 3.5 
VHMM Whole cells Acetate 34% 3.7 
VHMM Whole cells αKG 33% 3.4 
VHMM Whole cells NOG 27% 3.1 
VHMM Lysate None 73% 15.8 
VHMM Lysate Acetate 75% 16.9 
VHMM Lysate αKG 73% 14.3 
VHMM Lysate NOG 77% 17.0 
SDS-PAGE of PsEFE variants 
Large-scale protein expression, lysis, and purification was carried out as described in the methods section 
(Protein expression and purification). Whole-cell samples were taken after resuspension, clarified lysate 
samples were taken following sonication and centrifugation, and purified protein samples were taken after 
HisTrap purification. These samples were mixed 1:1 with 2X Laemmli loading buffer (Bio-Rad Laboratories, 
Inc.) with added 2-mercaptoethanol. Samples were heated to 95 °C in a thermomixer block, briefly centrifuged, 
and loaded on an Any kD™ Mini-PROTEAN® TGX™ Precast Protein Gels (Bio-Rad Laboratories, Inc.). Gels 
were run at 150 V for 30–45 minutes. Gels were washed with water, then stained by microwaving the gels with 
Coomassie solution. Gels were destained with successive rounds of microwaving with water, followed by gentle 
shaking overnight in water. 
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Aziridination variant protein purification 
  
Figure S1. SDS-PAGE of PsEFE aziridination variant T97M R171L R277H F314M C317M (PsEFE MLHMM). 
The protein is shown from left to right as whole-cell sample, clarified lysate sample, and purified protein 
sample. Whole cells and lysates were diluted 25-fold; purified protein was diluted 50-fold (each dilution is 
prior to addition of 2X Laemmli loading dye). The ladder and sample were run on the same gel; unrelated 
protein samples were cropped out for image clarity. The SDS-PAGE image brightness was increased in 
Microsoft Word for image clarity and is not being used for quantitation. 
C–H insertion variant protein purification 
 
Figure S2. SDS-PAGE of PsEFE C–H insertion variants. Each protein is shown from left to right as whole-cell 
sample, clarified lysate sample, and purified protein sample. Whole cells and lysates were diluted 25-fold; 
purified protein was diluted 50-fold (each dilution is prior to addition of 2X Laemmli loading dye). Protein 1: 
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R171V F314M C317M, Protein 2: R171V R277H F314M C317M. Protein 3: T97M R171V R277H F314L 
C317M. The SDS-PAGE image brightness was increased in Microsoft Word for image clarity and is not being 
used for quantitation.  
Reaction time courses 
Aziridination time course 
A time course was run with PsEFE WT and PsEFE MLLHMM, a variant with one additional mutation (I186L) 
relative to PsEFE MLHMM with decreased activity and slightly increased enantioselectivity. Purified protein 
reactions were set up in triplicate both anaerobically and aerobically, as described in the methods section above 
(Analytical-scale biocatalytic aziridination reactions). Time points were taken at 15 minutes, 30 minutes, 1 hour, 
2 hours, 3 hours, 4 hours, and 8 hours, at which point those reactions were quenched by addition of acetonitrile 
(350 μL) and the internal standard propiophenone (1 μL mL-1 in acetonitrile, 50 μL).  
As we see in Figure S3, the reaction with wild-type PsEFE is essentially done by the 15 minute mark, while the 
yield with MLLHMM continues to increase until approximately 2 hours. The reaction appears to proceed for a 
longer time anaerobically than aerobically for PsEFE MLLHMM; the low activity and fast reaction completion 
for wild-type PsEFE makes such comparisons challenging. 
 
Figure S3. Aziridination time course. Time courses denoted “air” were set up aerobically; time courses 
denoted “Coy” were set up anaerobically. 
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Evolved variant thermostability 
During our purified protein reactions, we do observe what is ostensibly protein precipitation over time. This 
visual observation, together with our time-course data, indicate that one possible reason for limited activity 
might be the protein’s stability to the reaction conditions over time. The thermostability of wild-type PsEFE has 
been measured with ITC3; not surprisingly, the protein is reported to have increased stability in the presence 
of iron and α-ketoglutarate. We used the thermal shift assay4 using SYPRO orange (Thermo Fisher Scientific). 
Thermal shift assay samples were prepared in triplicate anaerobically under similar conditions as described 
above (Reaction condition controls). To a PCR tube with purified PsEFE wild type or a PsEFE variant (stripped 
and dialyzed, 10–15 µM final concentration) was added (to a final concentration of 1.25 mM each) either: 
• ferrous ammonium sulfate 
• ferrous ammonium sulfate, L-ascorbic acid, and α-ketoglutarate 
• ferrous ammonium sulfate, L-ascorbic acid, and sodium acetate 
Following these additions, to each tube was added 5 µL SYPRO orange (25-fold diluted in water). The PCR 
tubes were sealed, brought out of the anaerobic chamber, and analyzed on an Stratagene Mx3005P qPCR 
machine (Agilent Technologies, Inc.). The temperature program ran from 25 °C to 99 °C, holding for 30 seconds 
per degree before measuring fluorescence on the SYPRO channel and increasing temperature. The melting 
temperature for a given temperature was taken as the maximum of the numerical first derivative, representing 
the inflection point of the protein’s melt curve.  
The data are presented in Figure S4. We can see that, even though beneficial mutations were only chosen 
based on activity and stereoselectivity, the protein’s stability improved from wild type to the final variants. We 
also see a significant enhancement in thermostability for early variants upon addition of α-ketoglutarate (noted 
as 2OG for 2-oxoglutarate), which is not observed in the later evolved variants. 
 
 
3 Li, M.; Martinez, S.; Hausinger, R. P.; Emerson, J. P. Thermodynamics of Iron(II) and Substrate Binding to the Ethylene-Forming 
Enzyme. Biochemistry 2018, 57, 5696-5705. 
4 Ericsson, U. B.; Hallberg, B. M.; DeTitta, G. T.; Dekker, N.; Nordlund, P. Thermofluor-based high-throughput stability optimization of 
proteins for structural studies. Anal. Biochem. 2006, 357, 289–298. 
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Figure S4. Thermostability of wild-type and evolved PsEFE variants for aziridination and intramolecular C-H 
insertion.  
Synthesis of sulfonyl azide substrates 
Safety statement 
Organic azides are potentially explosive compounds. We have not observed any problems in our handling of 
the compounds described, but care should be taken, especially on large scales. 
p-Toluenesulfonyl azide (2) 
 
Under air, p-toluenesulfonyl chloride (19.1 g, 100 mmol, 1.00 equiv.) was dissolved in acetone (200 mL) in a 
500 mL round-bottomed flask with a magnetic stir bar and cooled to 0 °C. A solution of sodium azide (9.75 g, 
150 mmol, 1.50 equiv.) in water (60 mL) was added dropwise over one hour with stirring. Once addition was 
complete, the reaction was allowed to warm to room temperature and stirred for 16 hours. The acetone was 
removed in vacuo, and the resulting mixture was extracted with diethyl ether (2×100 mL). The combined organic 
layers were washed with water (2×100 mL), saturated aqueous sodium bicarbonate (100 mL), and brine 
(100 mL), then dried over magnesium sulfate and concentrated in vacuo to afford the title compound as a 
colorless oil that solidified upon storage at −20 °C (19.1 g, 97%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.80 (d, J = 8.5 Hz, 2 H), 7.38 (d, J = 8.5 Hz, 2 H), 2.45 (s, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 146.3, 135.3, 130.3, 127.4, 21.7 
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2-Ethylbenzenesulfonyl chloride (S1)5 
 
Under argon, 1-bromo-2-ethylbenzene (2.07 mL, 2.78 g, 15.0 mmol, 1.00 equiv.) was dissolved in anhydrous 
tetrahydrofuran (30 mL) in a 100 mL round-bottomed flask with magnetic stirring and cooled to −40 °C. 
n‑Butyllithium (2.5 M solution in hexanes, 7.20 mL, 18.0 mmol, 1.20 equiv.) was added dropwise by syringe 
over two minutes. The reaction was stirred at −40 °C for thirty minutes, then sulfuryl chloride (1.82 mL, 3.04 g, 
22.5 mmol, 1.5 equiv.) was added dropwise by syringe over two minutes. The reaction was allowed to warm to 
room temperature and stirred for 16 hours. The reaction was cooled to 0 °C, then carefully quenched by the 
addition of ice-cold water (50 mL). The resulting mixture was extracted with diethyl ether (2×50 mL). The 
combined organic layers were dried over sodium sulfate and concentrated in vacuo. The residue was purified 
by flash column chromatography on silica (50 g), eluting with a gradient of 0 to 20% diethyl ether/hexanes, to 
afford the title compound as a slightly yellow oil (1.10 g, 36%). 
NMR Spectroscopy:  
1H NMR (400 MHz, CDCl3, 23 ºC, ): 8.07 (d, J = 8.1 Hz, 1 H), 7.66 (t, J = 7.5 Hz, 1 H), 7.49 (d, J = 
7.6 Hz, 1 H), 7.41 (t, J = 7.9 Hz, 1 H), 3.20 (q, J = 7.5 Hz, 2 H), 1.37 (t, J = 7.5 Hz, 3 H) 
2-Ethylbenzenesulfonyl azide (4)5 
 
Under air, 2-ethylbenzenesulfonyl chloride S1 (1.00 g, 4.89 mmol, 1.00 equiv.) was dissolved in acetone (8 mL) 
in a 20 mL scintillation vial with magnetic stirring and cooled to 0 °C. A solution of sodium azide (476 mg, 
7.33 mmol, 1.50 equiv.) in water (2.5 mL) was added dropwise over two minutes with stirring. Once addition 
was complete, the reaction was allowed to warm to room temperature and stirred for six hours. The acetone 
was removed in vacuo, and the resulting mixture was extracted with diethyl ether (2×15 mL). The combined 
organic layers were washed with water, saturated aqueous sodium bicarbonate, and brine (15 mL each), then 
dried over magnesium sulfate and concentrated in vacuo to afford the title compound as a yellow oil (1.01 g, 
98%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 8.01 (dd, J = 8.0, 1.3 Hz, 1 H), 7.62 (td, J = 7.6, 1.3 Hz, 1 H), 7.46 
 
5 Ichinose, M.; Suematsu, H.; Yasutomi, Y.; Nishioka, Y.; Uchida, T.; Katsuki, T. Enantioselective Intramolecular Benzylic C–H Bond 
Amination: Efficient Synthesis of Optically Active Benzosultams. Angew. Chem. Int. Ed. 2011, 50, 9884–9887. 
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(dd, J = 7.7, 0.7 Hz, 1 H), 7.37 (td, J = 8.0, 1.2 Hz, 1 H), 3.03 (q, J = 7.5 Hz, 2 H), 1.31 (t, J = 7.5 Hz, 
3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 144.5, 136.3, 134.9, 131.4, 129.4, 126.4, 26.1, 15.2 
Synthesis of authentic product standards 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
 
Under argon, chloramine-T trihydrate (4.23 g, 15.0 mmol, 1.00 equiv.) and iodine (381 mg, 1.50 mmol, 
0.100 equiv.) were dissolved in acetonitrile (100 mL). Styrene (3.45 mL, 3.13 g, 30.0 mmol, 2.00 equiv.) was 
added dropwise, and the reaction was stirred at room temperature for 18 hours. The reaction mixture was 
partitioned between water (50 mL) and dichloromethane (100 mL), and the layers were separated. The 
aqueous layer was extracted with dichloromethane (2×100 mL). The combined organic layers were 
concentrated in vacuo and the residue was purified by flash column chromatography on silica (100 g) eluting 
with hexanes/ethyl acetate (6:1 v/v) containing 1% triethylamine to afford the title compound as a colorless 
solid (3.55 g, 87%). 
NMR Spectroscopy: 
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.87 (d, J = 8.3 Hz, 2 H), 7.33 (d, J = 8.3 Hz, 2 H), 7.30–7.25 (m, 
3 H), 7.24–7.20 (m, 2 H), 3.78 (dd, J = 7.2, 4.5 Hz, 1 H), 2.99 (d, J = 7.2 Hz, 1 H), 2.44 (s, 3 H), 2.40 (d, 
J = 4.4 Hz, 1 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 144.8, 135.1, 135.0, 129.9, 128.7, 128.4, 128.1, 126.7, 41.2, 36.1, 
21.8 
3-Methylbenzo[d]isothiazole 1,1-dioxide (S2)6 
 
Under argon, saccharin (1.00 g, 5.46 mmol, 1.00 equiv.) was dissolved in anhydrous tetrahydrofuran (25 mL) 
in a 100 mL round-bottomed flask with magnetic stirring and cooled to 0 °C. Methylmagnesium bromide (3 M 
solution in diethyl ether, 4.00 mL, 12.0 mmol, 2.20 equiv.) was added dropwise by syringe over 10 minutes. 
 
6 Li, B.; Chen, J.; Zhang, Z.; Gridnev, I.Y., Zhang. W. Nickel-Catalyzed Asymmetric Hydrogenation of N-Sulfonyl Imines. Angew. Chem. 
Int. Ed. 2019, 58, 7329–7334. 
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After addition, the reaction was stirred at 0 °C for five minutes, then slowly warmed to room temperature and 
stirred at room temperature for 16 hours. The reaction was then cooled to 0 °C and carefully poured into ice-
cold hydrochloric acid (1 M, 30 mL). The resulting mixture was extracted with dichloromethane (2×50 mL). The 
combined organic layers were dried over sodium sulfate and concentrated in vacuo to afford the title compound 
as a colorless solid (crude yield 1.04 g, 105%) which was used in the next step without further purification. 
NMR Spectroscopy: 
1H NMR (400 MHz, CDCl3, 23 ºC, ): 7.94–7.90 (m, 1 H), 7.77–7.73 (m, 2 H), 7.71–7.67 (m, 1 H), 2.67 
(s, 3 H) 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
 
Under air, 3-methyl-[d]isothiazole 1,1-dioxide S2 (500 mg, 2.76 mmol, 1.00 equiv.) was dissolved in methanol 
(20 mL) in a 50 mL round-bottomed flask with magnetic stirring. Sodium borohydride (522 mg, 13.8 mmol, 
5.00 equiv.) was slowly added over two minutes. The reaction mixture bubbled vigorously and became warm 
to the touch. The reaction was stirred at room temperature for thirty minutes to ensure complete reaction. The 
reaction was cooled to 0 °C, then poured carefully into cold hydrochloric acid (2.5 M, 40 mL). The methanol 
was removed in vacuo and the resulting mixture was extracted with dichloromethane (3×25 mL). The combined 
organic layers were dried over sodium sulfate and concentrated in vacuo. The residue was purified by flash 
column chromatography on silica (25 g), eluting with a gradient of 10 to 60% ethyl acetate/hexanes to afford 
the title compound as a colorless solid (378 mg, 75%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.74 (d, J = 8.0 Hz, 1 H), 7.61 (td, J = 7.6, 1.0 Hz, 1 H), 7.50 (t, J = 
7.6 Hz, 1 H), 7.38 (d, J = 7.7 Hz, 1 H), 5.15 (br d, J = 4.8 Hz, 1 H), 4.78 (qd, J = 6.7, 4.8 Hz, 1 H), 1.59 
(d, J = 6.7 Hz, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ): 141.8, 135.4, 133.3, 129.2, 124.0, 121.2, 53.5, 21.5 
2-Ethylbenzenesulfonamide (6) 
 
Under air, 2-ethylbenzenesulfonyl chloride S1 (50.0 mg, 244 μmol, 1.00 equiv.) was dissolved in 
tetrahydrofuran (1 mL) in a 4 mL vial with magnetic stirring and cooled to 0 °C. Ammonia (28% w/v in water, 
149 μL, 2.44 mmol, 10.0 equiv.) was added dropwise over one minute. After stirring for five minutes, the 
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reaction mixture was partitioned between water and ethyl acetate (10 mL each). The layers were separated 
and the aqueous layer was extracted with ethyl acetate (2×10 mL). The combined organic layers were washed 
with brine (10 mL), dried over sodium sulfate, and concentrated in vacuo to afford the title compound as a 
colorless solid (41.8 mg, 92%). 
NMR Spectroscopy:  
1H NMR (500 MHz, CDCl3, 23 ºC, ): 7.99 (d, J = 8.0 Hz, 1 H), 7.51 (t, J = 7.5 Hz, 1 H), 7.39 (d, J = 7.6 Hz, 
1 H), 7.29 (t, J = 7.7 Hz, 1 H), 5.02 (br s, 2 H), 3.07 (q, J = 7.5 Hz, 2 H), 1.33 (t, J = 7.5 Hz, 3 H) 
13C NMR (125 MHz, CDCl3, 23 ºC, ):143.0, 139.6, 133.1, 130.7, 128.3, 126.2, 26.1, 15.3 
 
HPLC analytical methods and calibration curves 
Aziridination reaction 
 
Samples for HPLC calibration curves were prepared as simulated reaction samples. To MOPS buffer (20 mM 
pH 7.0, 380 μL) was added a solution of the appropriate reaction product in acetonitrile (0–100 μM, 20 μL, final 
concentration 0–5 mM). To this sample was added the internal standard propiophenone (0.1% v/v in acetonitrile, 
50 μL) and acetonitrile (350 μL). The product concentration in the curves below corresponds to the 
concentration in the reaction mixture; the final analytical sample is two-fold diluted. 
Analysis was performed on an Agilent 1200 series HPLC with water/acetonitrile mobile phase (1 mL min-1 flow), 
with an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a Poroshell 120 guard 
column (1.7 μm packing, 2.1×5 mm), injecting 5 μL. Detection was at 230 nm (16 nm bandwidth). The gradient 
program and retention times are given in Table S7 and Table S8, respectively. 
Table S7. HLPC gradient program for aziridination analysis 
Time (minutes) % Acetonitrile 
0.00 20 
0.50 20 
1.00 40 
5.00 65 
5.50 95 
6.00 95 
6.01 20 
7.00 20 
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Table S8. HPLC retention times for aziridination analysis 
Compound Retention time (minutes) 
p-Toluenesulfonamide 0.58 
Propiophenone 2.24 
p-Toluenesulfonyl azide 2.81 
Styrene 3.01 
2-Phenyl-1-(p-toluenesulfonyl)aziridine 3.45 
 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (3) calibration curve 
 
p-Toluenesulfonamide (S3) calibration curve 
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C–H insertion reaction 
 
Calibration curve samples were prepared as described above for the aziridination reaction, except the internal 
standard used was propiophenone (0.5% v/v in acetonitrile, 50 μL) and the final product concentrations ranged 
from 1–10 mM. The product concentration shown corresponds to the concentration in the reaction mixture; the 
final analytical sample is twofold diluted. 
Analysis was performed on an Agilent 1260 Infinity II HPLC instrument with water/acetonitrile mobile phase 
(1 mL min-1 flow), with an Agilent Poroshell 120 EC-C18 column (4 μm packing, 2.1×50 mm) fitted with a 
Poroshell 120 guard column (1.7 μm packing, 2.1×5 mm), injecting 5 μL. Detection was at 220 nm (4 nm 
bandwidth). The gradient program and retention times are given in Table S9 and Table S10, respectively. 
Table S9. HPLC gradient program for C–H insertion analysis 
Time (minutes) % Acetonitrile 
0.00 12 
1.00 12 
3.50 95 
4.00 95 
4.01 12 
5.00 12 
 
Table S10. HPLC retention times for C–H insertion analysis 
Compound Retention time (minutes) 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide 1.05 
2-Ethylbenzenesulfonamide 2.38 
Propiophenone 3.00 
2-Ethylbenzenesulfonyl azide 3.48 
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3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (5) calibration curve 
 
2-Ethylbenzenesulfonamide (6) calibration curve 
 
Chiral analysis 
Chiral analysis was performed by HPLC with a chiral stationary phase, using a Hewlett Packard Series 1100 
HPLC instrument with hexanes/2-propanol mobile phase (1 mL min-1 flow). 
2-Phenyl-1-(p-toluenesulfonyl)aziridine (3) 
Analysis was performed with a Daicel Chiralcel OJ-H column, (5 μm packing, 4.6×250 mm), with an isocratic 
30% 2-propanol/70% hexanes mobile phase. The peak areas were analyzed at 235 nm (16 nm bandwidth). 
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Figure S5. Chiral HPLC trace of rac-3. 
 
 
Figure S6. Chiral HPLC trace of PsEFE MLHMM-catalyzed product 3. 
 
 
3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (5) 
Analysis was performed with a Daicel Chiralpak IB column (5 μm packing, 4.6×250 mm), with an isocratic 25% 
2-propanol/75% hexanes mobile phase. The peak areas were analyzed at 220 nm (16 nm bandwidth). 
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Figure S7. Chiral HPLC trace of rac-5. 
 
 
Figure S8. Chiral HPLC trace of PsEFE VMM-catalyzed product 5.  
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SPECTROSCOPIC DATA 
1H NMR spectrum of p-Toluenesulfonyl azide (2) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of p-Toluenesulfonyl azide (2)  
125 MHz, CDCl3, 23 °C 
 
  
SUPPORTING INFORMATION   S26 
1H NMR spectrum of 2-Ethylbenzenesulfonyl chloride (S1) 
400 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Ethylbenzenesulfonyl azide (4) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 2-Ethylbenzenesulfonyl azide (4) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
500 MHz, CDCl3, 23 ° C 
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13C NMR spectrum of 2-Phenyl-1-(p-toluenesulfonyl)aziridine (rac-3) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 3-Methylbenzo[d]isothiazole 1,1-dioxide (S2) 
400 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 3-Methyl-2,3-dihydrobenzo[d]isothiazole 1,1-dioxide (rac-5) 
125 MHz, CDCl3, 23 °C 
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1H NMR spectrum of 2-Ethylbenzenesulfonamide (6) 
500 MHz, CDCl3, 23 °C 
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13C NMR spectrum of 2-Ethylbenzenesulfonamide (6) 
125 MHz, CDCl3, 23 °C 
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